Search Within

Zoe Goldberg

Formats
  1. Journal Article (7)
  2. Meeting Abstract (7)
  3. Miscellaneous (1)
Groups
  1. Department of Medicine (15)
  2. Gastrointestinal Oncology Service (15)
  3. Solid Tumor Oncology Division (15)
  4. Center for Pancreatic Cancer Research (14)
  5. Hematologic Malignancies, Division of (14)
  6. Survivorship Research (12)

More Groups

People
  1. Geoffrey Ku (12)
  2. Joanne Chou (10)
  3. Marinela Capanu (9)
  4. Avni Desai (8)
  5. Yelena Janjigian (8)
  6. Alice Zervoudakis (7)

More People

Years
  1. 2024 (1)
  2. 2023 (3)
  3. 2022 (1)
  4. 2021 (2)
  5. 2020 (3)
  6. 2019 (2)

More Years

Publications
  1. Journal of Clinical Oncology (5)
  2. Annals of Oncology (3)
  3. Cancer (1)
  4. Clinical Cancer Research (1)
  5. Clinical Nuclear Medicine (1)
  6. Gastric Cancer (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (5)
  2. Oxford University Press (4)
  3. American Association for Cancer Research (1)
  4. American Medical Association (1)
  5. Elsevier Science, Inc. (1)
  6. Lippincott Williams & Wilkins (1)

More Publishers

Results (15)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Efficacy of combined VEGFR1-3, PDGFα/β, and FGFR1-3 blockade using nintedanib for esophagogastric cancer
    Journal Article

    Won, E.; Basunia, A.; Chatila, W. K.; Hechtman, J. F.; Chou, J. F.; Ku, G. Y.; Chalasani, S. B.; Boyar, M. S.; Goldberg, Z.; Desai, A. M.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancer
    Journal Article

    Mondaca, S.; Margolis, M.; Sanchez-Vega, F.; Jonsson, P.; Riches, J. C.; Ku, G. Y.; Hechtman, J. F.; Tuvy, Y.; Berger, M. F.; Shah, M. A.; more...
    Gastric Cancer (2019)

    Fulltext@MSK | Save
  • Pilot study of gemcitabine, nab-paclitaxel, PEGPH20, and rivaroxaban for advanced pancreatic adenocarcinoma: An interim analysis
    Meeting Abstract

    Yu, K. H.; Mantha, S.; Tjan, C.; Kaufmann, E. S.; Brenner, R.; Lowery, M. A.; Ku, G. Y.; Raj, N. P.; Shcherba, M.; Goldberg, Z.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A pilot study of gemcitabine, nab-paclitaxel, PEGPH20 (PAG) and rivaroxaban for advanced pancreatic adenocarcinoma: Interim safety and efficacy analysis
    Meeting Abstract

    Yu, K.; Mantha, S.; Tjan, C.; Kaufmann, E.; Brenner, R. B.; Lowery, M.; Ku, G.; Raj, N.; Shcherba, M.; Goldberg, Z.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Phase II study of FOLFOX plus regorafenib (REGO) in patients with unresectable or metastatic esophagogastric (EG) cancer
    Meeting Abstract

    Janjigian, Y. Y.; Ku, G. Y.; Chou, J. F.; Capanu, M.; Siebel, M.; Chalasani, S. B.; Boyar, M. S.; Goldberg, Z.; Desai, A. M.; Kelsen, D. P.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save